NO304397B1 - FremgangsmÕte og apparat for Õ generere en avbildning av en pr°ve ved kjernemagnetisk resonans, samt kontrastmedium til bruk i slik fremgangsmÕte - Google Patents
FremgangsmÕte og apparat for Õ generere en avbildning av en pr°ve ved kjernemagnetisk resonans, samt kontrastmedium til bruk i slik fremgangsmÕte Download PDFInfo
- Publication number
- NO304397B1 NO304397B1 NO895229A NO895229A NO304397B1 NO 304397 B1 NO304397 B1 NO 304397B1 NO 895229 A NO895229 A NO 895229A NO 895229 A NO895229 A NO 895229A NO 304397 B1 NO304397 B1 NO 304397B1
- Authority
- NO
- Norway
- Prior art keywords
- radiation
- sample
- image
- paramagnetic material
- frequency
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 53
- 239000002872 contrast media Substances 0.000 title claims description 46
- 238000005481 NMR spectroscopy Methods 0.000 title claims description 13
- 230000005855 radiation Effects 0.000 claims abstract description 98
- 230000007704 transition Effects 0.000 claims abstract description 74
- 230000005291 magnetic effect Effects 0.000 claims abstract description 35
- 239000002907 paramagnetic material Substances 0.000 claims description 29
- -1 cyclic nitroxide Chemical class 0.000 claims description 17
- 238000001208 nuclear magnetic resonance pulse sequence Methods 0.000 claims description 15
- 238000004435 EPR spectroscopy Methods 0.000 claims description 12
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical class ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 claims description 8
- 125000004432 carbon atom Chemical group C* 0.000 claims description 7
- 229920006395 saturated elastomer Polymers 0.000 claims description 7
- 229910052760 oxygen Inorganic materials 0.000 claims description 6
- 239000001301 oxygen Substances 0.000 claims description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 5
- 241001465754 Metazoa Species 0.000 claims description 5
- 229910052799 carbon Inorganic materials 0.000 claims description 5
- 230000001105 regulatory effect Effects 0.000 claims description 4
- 229910052717 sulfur Inorganic materials 0.000 claims description 4
- 230000001131 transforming effect Effects 0.000 claims description 4
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 2
- 239000011593 sulfur Substances 0.000 claims description 2
- 125000004434 sulfur atom Chemical group 0.000 claims description 2
- 125000004122 cyclic group Chemical group 0.000 claims 1
- 125000004430 oxygen atom Chemical group O* 0.000 claims 1
- 230000006698 induction Effects 0.000 abstract description 4
- 238000003384 imaging method Methods 0.000 description 33
- 238000002595 magnetic resonance imaging Methods 0.000 description 27
- 210000001519 tissue Anatomy 0.000 description 23
- 230000005415 magnetization Effects 0.000 description 21
- 230000005298 paramagnetic effect Effects 0.000 description 17
- 238000001514 detection method Methods 0.000 description 15
- 230000000694 effects Effects 0.000 description 14
- 239000000126 substance Substances 0.000 description 14
- 230000008878 coupling Effects 0.000 description 12
- 238000010168 coupling process Methods 0.000 description 12
- 238000005859 coupling reaction Methods 0.000 description 12
- 150000003254 radicals Chemical class 0.000 description 12
- 125000000217 alkyl group Chemical group 0.000 description 11
- 238000001362 electron spin resonance spectrum Methods 0.000 description 10
- 230000009467 reduction Effects 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 230000005283 ground state Effects 0.000 description 7
- 230000000977 initiatory effect Effects 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 239000000463 material Substances 0.000 description 6
- 239000002616 MRI contrast agent Substances 0.000 description 5
- 125000004429 atom Chemical group 0.000 description 5
- 238000002075 inversion recovery Methods 0.000 description 5
- 230000005414 paramagnetic center Effects 0.000 description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 230000005284 excitation Effects 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- 238000002059 diagnostic imaging Methods 0.000 description 3
- 230000005281 excited state Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 230000000155 isotopic effect Effects 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 230000006641 stabilisation Effects 0.000 description 3
- 238000011105 stabilization Methods 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 125000003161 (C1-C6) alkylene group Chemical group 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 229910052688 Gadolinium Inorganic materials 0.000 description 1
- GQPLMRYTRLFLPF-UHFFFAOYSA-N Nitrous Oxide Chemical class [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 description 1
- 241000276498 Pollachius virens Species 0.000 description 1
- 230000018199 S phase Effects 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 125000004450 alkenylene group Chemical group 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- 125000002837 carbocyclic group Chemical group 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000012631 diagnostic technique Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 238000011067 equilibration Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 230000005294 ferromagnetic effect Effects 0.000 description 1
- UIWYJDYFSGRHKR-UHFFFAOYSA-N gadolinium atom Chemical compound [Gd] UIWYJDYFSGRHKR-UHFFFAOYSA-N 0.000 description 1
- SQORATIMOBOFKR-UHFFFAOYSA-H gadolinium(3+);oxalate Chemical compound [Gd+3].[Gd+3].[O-]C(=O)C([O-])=O.[O-]C(=O)C([O-])=O.[O-]C(=O)C([O-])=O SQORATIMOBOFKR-UHFFFAOYSA-H 0.000 description 1
- 230000020169 heat generation Effects 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011503 in vivo imaging Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 125000004043 oxo group Chemical group O=* 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000002601 radiography Methods 0.000 description 1
- 210000005227 renal system Anatomy 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- UGNWTBMOAKPKBL-UHFFFAOYSA-N tetrachloro-1,4-benzoquinone Chemical compound ClC1=C(Cl)C(=O)C(Cl)=C(Cl)C1=O UGNWTBMOAKPKBL-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/48—NMR imaging systems
- G01R33/54—Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
- G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
- G01R33/5601—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/20—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations containing free radicals, e.g. trityl radical for overhauser
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/28—Details of apparatus provided for in groups G01R33/44 - G01R33/64
- G01R33/282—Means specially adapted for hyperpolarisation or for hyperpolarised contrast agents, e.g. for the generation of hyperpolarised gases using optical pumping cells, for storing hyperpolarised contrast agents or for the determination of the polarisation of a hyperpolarised contrast agent
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/62—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using double resonance
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- General Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- High Energy & Nuclear Physics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Signal Processing (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Structures Of Non-Positive Displacement Pumps (AREA)
- Hard Magnetic Materials (AREA)
- Water Treatment By Electricity Or Magnetism (AREA)
- Soft Magnetic Materials (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB878714615A GB8714615D0 (en) | 1987-06-23 | 1987-06-23 | Apparatus |
GB878714804A GB8714804D0 (en) | 1987-06-24 | 1987-06-24 | Apparatus |
PCT/GB1988/000479 WO1988010419A1 (fr) | 1987-06-23 | 1988-06-22 | Ameliorations apportees a la formation d'images par resonance magnetique |
Publications (3)
Publication Number | Publication Date |
---|---|
NO895229D0 NO895229D0 (no) | 1989-12-22 |
NO895229L NO895229L (no) | 1989-12-22 |
NO304397B1 true NO304397B1 (no) | 1998-12-07 |
Family
ID=26292386
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO895229A NO304397B1 (no) | 1987-06-23 | 1989-12-22 | FremgangsmÕte og apparat for Õ generere en avbildning av en pr°ve ved kjernemagnetisk resonans, samt kontrastmedium til bruk i slik fremgangsmÕte |
Country Status (16)
Country | Link |
---|---|
US (1) | US4984573A (fr) |
EP (2) | EP0296833B1 (fr) |
JP (2) | JP2690987B2 (fr) |
AT (1) | ATE111231T1 (fr) |
AU (1) | AU610910B2 (fr) |
DE (2) | DE3851442T2 (fr) |
DK (1) | DK622489D0 (fr) |
ES (2) | ES2026257T3 (fr) |
FI (1) | FI896234A0 (fr) |
GB (1) | GB2234072B (fr) |
GR (1) | GR3002798T3 (fr) |
IE (1) | IE61448B1 (fr) |
NO (1) | NO304397B1 (fr) |
NZ (1) | NZ225145A (fr) |
PH (1) | PH27135A (fr) |
WO (1) | WO1988010419A1 (fr) |
Families Citing this family (89)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5203332A (en) * | 1987-06-23 | 1993-04-20 | Nycomed Imaging As | Magnetic resonance imaging |
GB8718515D0 (en) * | 1987-08-05 | 1987-09-09 | Nat Res Dev | Obtaining images |
GB8817137D0 (en) * | 1988-07-19 | 1988-08-24 | Nycomed As | Compositions |
GB8819753D0 (en) * | 1988-08-19 | 1988-09-21 | Nycomed As | Apparatus |
FI80796C (fi) * | 1988-09-12 | 1990-07-10 | Instrumentarium Oy | Arrangemang foer materialundersoekning. |
US5218964A (en) * | 1988-10-21 | 1993-06-15 | Instrumentarium Corp. | Method for providing accurate reference markers in magnetic resonance images |
US5314681A (en) * | 1988-12-23 | 1994-05-24 | Nycomed Innovation Ab | Composition of positive and negative contrast agents for electron spin resonance enhanced magnetic resonance imaging |
GB8830215D0 (en) * | 1988-12-23 | 1989-02-22 | Hafslund Nycomed Innovation | Method |
GB8909270D0 (en) * | 1989-04-24 | 1989-06-07 | Hafslund Nycomed Innovation | Method |
FR2653251A1 (fr) * | 1989-10-13 | 1991-04-19 | Centre Nat Rech Scient | Procede d'authentification d'un objet par resonance paramagnetique electronique appareillage pour sa mise en óoeuvre et objet utilisable avec le procede. |
FI85193C (fi) * | 1989-11-27 | 1992-03-10 | Instrumentarium Oy | Undersoekningsfoerfarande och - anordning. |
US5922304A (en) | 1989-12-22 | 1999-07-13 | Imarx Pharmaceutical Corp. | Gaseous precursor filled microspheres as magnetic resonance imaging contrast agents |
US6001335A (en) * | 1989-12-22 | 1999-12-14 | Imarx Pharmaceutical Corp. | Contrasting agents for ultrasonic imaging and methods for preparing the same |
US5469854A (en) * | 1989-12-22 | 1995-11-28 | Imarx Pharmaceutical Corp. | Methods of preparing gas-filled liposomes |
US5542935A (en) | 1989-12-22 | 1996-08-06 | Imarx Pharmaceutical Corp. | Therapeutic delivery systems related applications |
US5585112A (en) * | 1989-12-22 | 1996-12-17 | Imarx Pharmaceutical Corp. | Method of preparing gas and gaseous precursor-filled microspheres |
US6551576B1 (en) | 1989-12-22 | 2003-04-22 | Bristol-Myers Squibb Medical Imaging, Inc. | Container with multi-phase composition for use in diagnostic and therapeutic applications |
US20020150539A1 (en) * | 1989-12-22 | 2002-10-17 | Unger Evan C. | Ultrasound imaging and treatment |
US6088613A (en) | 1989-12-22 | 2000-07-11 | Imarx Pharmaceutical Corp. | Method of magnetic resonance focused surgical and therapeutic ultrasound |
US5776429A (en) * | 1989-12-22 | 1998-07-07 | Imarx Pharmaceutical Corp. | Method of preparing gas-filled microspheres using a lyophilized lipids |
US6146657A (en) * | 1989-12-22 | 2000-11-14 | Imarx Pharmaceutical Corp. | Gas-filled lipid spheres for use in diagnostic and therapeutic applications |
GB8929300D0 (en) * | 1989-12-29 | 1990-02-28 | Instrumentarium Corp | Apparatus |
JP3175940B2 (ja) * | 1990-02-12 | 2001-06-11 | ニコムド イノベーション アーベー | トリアリールメチルラジカルおよび磁気共鳴造影法における不活性炭素フリーラジカルの用途 |
GB9006320D0 (en) * | 1990-03-21 | 1990-05-16 | Gen Electric Co Plc | Nuclear magnetic resonance apparatus |
GB9007636D0 (en) * | 1990-04-04 | 1990-05-30 | Instrumentarium Corp | Mri coil |
US5144236A (en) * | 1990-08-17 | 1992-09-01 | Strenk Scientific Consultants, Inc. | Method and apparatus for r.f. tomography |
WO1992004640A1 (fr) * | 1990-09-06 | 1992-03-19 | British Technology Group Ltd | Procede d'obtention d'images representant la repartition d'une matiere paramagnetique dans une solution |
GB9024527D0 (en) * | 1990-11-12 | 1991-01-02 | Instrumentarium Corp | Improvements in and relating to magnetic resonance imaging |
GB9024528D0 (en) * | 1990-11-12 | 1991-01-02 | Instrumentarium Corp | Improvements in and relating to magnetic resonance imaging |
GB2253702B (en) * | 1991-03-12 | 1995-03-22 | Instrumentarium Corp | apparatus and method |
US5564421A (en) * | 1991-04-04 | 1996-10-15 | Instrumentarium Corporation | VHF applicator for magnetic resonance imaging |
US5874062A (en) * | 1991-04-05 | 1999-02-23 | Imarx Pharmaceutical Corp. | Methods of computed tomography using perfluorocarbon gaseous filled microspheres as contrast agents |
US5205290A (en) | 1991-04-05 | 1993-04-27 | Unger Evan C | Low density microspheres and their use as contrast agents for computed tomography |
GB9111738D0 (en) * | 1991-05-31 | 1991-07-24 | Instrumentarium Corp | Method |
US5245282A (en) * | 1991-06-28 | 1993-09-14 | University Of Virginia Alumni Patents Foundation | Three-dimensional magnetic resonance imaging |
US5189370A (en) * | 1991-08-16 | 1993-02-23 | Siemens Aktiengesellschaft | Chemical shift imaging |
GB9216597D0 (en) * | 1992-08-05 | 1992-09-16 | British Tech Group | Method of obtaining images representing the distribution of paramagnetic material in solution |
US5453692A (en) * | 1992-08-06 | 1995-09-26 | Hitachi, Ltd. | RF probe for nuclear magnetic resonance imaging (MRI) devices |
GB9518442D0 (en) * | 1995-09-08 | 1995-11-08 | Nycomed Imaging As | Method |
US5468467A (en) * | 1993-04-23 | 1995-11-21 | Bracco International B.V. | Methods for the in vivo measurement of the concentration of non-imaging nmr-detectable xenobiotic compounds |
US7083572B2 (en) * | 1993-11-30 | 2006-08-01 | Bristol-Myers Squibb Medical Imaging, Inc. | Therapeutic delivery systems |
DK143193A (da) * | 1993-12-22 | 1995-06-23 | Ardenkjaer Larsen Jan Henrik | Fremgangsmåde og apparat til måling af svage magnetiske felter |
DE69533692T2 (de) * | 1994-07-28 | 2005-10-27 | Koninklijke Philips Electronics N.V. | Anordnung von rf-spulen für ein gerät der magnetischen resonanz |
US5685305A (en) * | 1994-08-05 | 1997-11-11 | The United States Of America As Represented By The Department Of Health And Human Services | Method and system for MRI detection of abnormal blood flow |
US6743779B1 (en) | 1994-11-29 | 2004-06-01 | Imarx Pharmaceutical Corp. | Methods for delivering compounds into a cell |
US5830430A (en) * | 1995-02-21 | 1998-11-03 | Imarx Pharmaceutical Corp. | Cationic lipids and the use thereof |
DE69634908T2 (de) * | 1995-04-18 | 2006-04-27 | Koninklijke Philips Electronics N.V. | Rf-spulenanordnung für ein gerät für magnetische resonanzuntersuchungen |
US5997898A (en) * | 1995-06-06 | 1999-12-07 | Imarx Pharmaceutical Corp. | Stabilized compositions of fluorinated amphiphiles for methods of therapeutic delivery |
US6521211B1 (en) | 1995-06-07 | 2003-02-18 | Bristol-Myers Squibb Medical Imaging, Inc. | Methods of imaging and treatment with targeted compositions |
US6139819A (en) * | 1995-06-07 | 2000-10-31 | Imarx Pharmaceutical Corp. | Targeted contrast agents for diagnostic and therapeutic use |
US6033645A (en) * | 1996-06-19 | 2000-03-07 | Unger; Evan C. | Methods for diagnostic imaging by regulating the administration rate of a contrast agent |
US6231834B1 (en) | 1995-06-07 | 2001-05-15 | Imarx Pharmaceutical Corp. | Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same |
US5782764A (en) * | 1995-11-07 | 1998-07-21 | Iti Medical Technologies, Inc. | Fiber composite invasive medical instruments and methods for use in interventional imaging procedures |
US5744958A (en) * | 1995-11-07 | 1998-04-28 | Iti Medical Technologies, Inc. | Instrument having ultra-thin conductive coating and method for magnetic resonance imaging of such instrument |
JP2001507207A (ja) | 1996-05-01 | 2001-06-05 | イマアーレクス・フアーマシユーチカル・コーポレーシヨン | 化合物を細胞に送達する方法 |
US6414139B1 (en) | 1996-09-03 | 2002-07-02 | Imarx Therapeutics, Inc. | Silicon amphiphilic compounds and the use thereof |
US5846517A (en) | 1996-09-11 | 1998-12-08 | Imarx Pharmaceutical Corp. | Methods for diagnostic imaging using a renal contrast agent and a vasodilator |
ES2189974T3 (es) * | 1996-09-11 | 2003-07-16 | Imarx Pharmaceutical Corp | Procedimientos mejorados para la obtencion de imagenes de diagnostico usando un agente de contraste y un vasodilatador. |
US6143276A (en) * | 1997-03-21 | 2000-11-07 | Imarx Pharmaceutical Corp. | Methods for delivering bioactive agents to regions of elevated temperatures |
US6090800A (en) * | 1997-05-06 | 2000-07-18 | Imarx Pharmaceutical Corp. | Lipid soluble steroid prodrugs |
US6537246B1 (en) * | 1997-06-18 | 2003-03-25 | Imarx Therapeutics, Inc. | Oxygen delivery agents and uses for the same |
GB9706282D0 (en) * | 1997-03-26 | 1997-05-14 | Nycomed Imaging As | Method |
US20050019266A1 (en) * | 1997-05-06 | 2005-01-27 | Unger Evan C. | Novel targeted compositions for diagnostic and therapeutic use |
US6416740B1 (en) | 1997-05-13 | 2002-07-09 | Bristol-Myers Squibb Medical Imaging, Inc. | Acoustically active drug delivery systems |
US6548047B1 (en) | 1997-09-15 | 2003-04-15 | Bristol-Myers Squibb Medical Imaging, Inc. | Thermal preactivation of gaseous precursor filled compositions |
US6123923A (en) * | 1997-12-18 | 2000-09-26 | Imarx Pharmaceutical Corp. | Optoacoustic contrast agents and methods for their use |
US6278893B1 (en) | 1998-01-05 | 2001-08-21 | Nycomed Imaging As | Method of magnetic resonance imaging of a sample with ex vivo polarization of an MR imaging agent |
US20010003580A1 (en) | 1998-01-14 | 2001-06-14 | Poh K. Hui | Preparation of a lipid blend and a phospholipid suspension containing the lipid blend |
FI105447B (fi) * | 1998-11-03 | 2000-08-31 | Raimo Pentti Juhani Joensuu | Järjestely kohteen tutkimiseen |
US6489872B1 (en) | 1999-05-06 | 2002-12-03 | New Mexico Resonance | Unilateral magnet having a remote uniform field region for nuclear magnetic resonance |
GB0014463D0 (en) * | 2000-06-14 | 2000-08-09 | Nycomed Amersham Plc | NMR Method |
US20080095713A1 (en) | 2004-07-30 | 2008-04-24 | Mikkel Thaning | Method of Tumour Imaging |
US20070025918A1 (en) * | 2005-07-28 | 2007-02-01 | General Electric Company | Magnetic resonance imaging (MRI) agents: water soluble carbon-13 enriched fullerene and carbon nanotubes for use with dynamic nuclear polarization |
ATE534407T1 (de) | 2005-12-01 | 2011-12-15 | Ge Healthcare As | Verfahren zur dynamischen kernpolarisation (dnp) unter verwendung eines tritylrests und eines paramagnetischen metallions |
EP1960001A2 (fr) | 2005-12-08 | 2008-08-27 | Koninklijke Philips Electronics N.V. | Systeme et procede permettant de surveiller la liberation de medicaments in vivo par rmn amelioree par effet overhauser |
JP5269791B2 (ja) | 2006-08-30 | 2013-08-21 | ジーイー・ヘルスケア・アクスイェ・セルスカプ | 動的核分極(dnp)方法並びに該方法で使用するための化合物及び組成物 |
EP2072061A1 (fr) | 2007-12-19 | 2009-06-24 | GE Healthcare Limited | Composition et procédé pour générer un profil métabolique par 13C-MR |
US8968703B2 (en) | 2009-09-10 | 2015-03-03 | Ge Healthcare Limited | 13C-MR detection using hyperpolarised 13C-fructose |
US8664955B1 (en) | 2010-02-22 | 2014-03-04 | Howard J. Halpern | High-isolation transmit/receive surface coils and method for EPRI |
EP2555803B1 (fr) | 2010-04-08 | 2018-09-12 | Bracco Imaging S.p.A | Procédé de préparation de substrats hyperpolarisés et procédé d'irm |
FI128224B (fi) * | 2010-08-31 | 2020-01-15 | Vaisala Oyj | Matalakenttäinen ydinmagneettiresonanssilaite kiintoaineiden ja lietteiden vesipitoisuuden mittaamiseksi |
WO2013053839A1 (fr) | 2011-10-12 | 2013-04-18 | Bracco Imaging Spa | Procédé de préparation de dérivés hyperpolarisés pour une utilisation dans une analyse irm |
WO2013083535A1 (fr) | 2011-12-05 | 2013-06-13 | Bracco Imaging Spa | Composition comprenant de l'anhydride acétique et un complexe de gadolinium, et procédé d'utilisation dans l'analyse irm avec hyperpolarisation |
EP2833924B1 (fr) | 2012-04-02 | 2019-05-08 | Bracco Imaging S.p.A | Acides aminés hyperpolarisés |
CN104193673B (zh) * | 2014-08-14 | 2016-03-23 | 南开大学 | 一种以三联吡啶为骨架含苯砜基的顺磁荧光双功能探针 |
MX366786B (es) * | 2014-09-05 | 2019-07-23 | Hyperfine Res Inc | Metodos y aparato de supresion de ruido. |
DE112019003978T5 (de) * | 2018-08-09 | 2021-06-02 | Socpra Sciences Et Genie S.E.C. | System und verfahren zum erkennen von spin |
JPWO2022264970A1 (fr) * | 2021-06-14 | 2022-12-22 | ||
JPWO2022264971A1 (fr) * | 2021-06-14 | 2022-12-22 |
Family Cites Families (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3959287A (en) * | 1972-07-10 | 1976-05-25 | Syva Company | Ligand determination of spin labeled compounds by receptor displacement |
CA1001232A (en) * | 1973-11-30 | 1976-12-07 | Ivan Hrvoic | Nuclear dynamic polarization magnetometer |
US4048555A (en) * | 1976-06-15 | 1977-09-13 | Bell Telephone Laboratories, Incorporated | Spin resonance spectrometer and magnet structure |
GB1578910A (en) * | 1978-05-25 | 1980-11-12 | Emi Ltd | Imaging systems |
DE2840178A1 (de) * | 1978-09-15 | 1980-03-27 | Philips Patentverwaltung | Magnetspulenanordnung zur erzeugung von linearen magnetischen gradientenfeldern |
US4354499A (en) * | 1978-11-20 | 1982-10-19 | Damadian Raymond V | Apparatus and method for nuclear magnetic resonance scanning and mapping |
US4442404A (en) * | 1978-12-19 | 1984-04-10 | Bergmann Wilfried H | Method and means for the noninvasive, local, in-vivo examination of endogeneous tissue, organs, bones, nerves and circulating blood on account of spin-echo techniques |
GB2049191B (en) * | 1979-02-23 | 1983-06-15 | Newport Instr Ltd | Methods of quantitative analysis |
DE2917794C2 (de) * | 1979-05-03 | 1986-03-13 | Bruker Analytische Meßtechnik GmbH, 7512 Rheinstetten | Bimodaler Resonator für Elektronenspinresonanz-Experimente |
US4339716A (en) * | 1979-05-23 | 1982-07-13 | Picker International Limited | Nuclear magnetic resonance systems |
NL7904986A (nl) * | 1979-06-27 | 1980-12-30 | Philips Nv | Werkwijze en inrichting voor het bepalen van een kernspindichtheidsverdeling in een deel van een lichaam. |
US4307343A (en) * | 1979-08-20 | 1981-12-22 | General Electric Company | Moving gradient zeugmatography |
JPS6051056B2 (ja) * | 1980-06-13 | 1985-11-12 | 株式会社東芝 | 核磁気共鳴装置 |
JPS576347A (en) * | 1980-06-13 | 1982-01-13 | Toshiba Corp | Nuclear magnetic resonator |
DE3022481C2 (de) * | 1980-06-14 | 1985-01-24 | Bruker Analytische Meßtechnik GmbH, 7512 Rheinstetten | Probenkopf für paramagnetische Elektronenresonanz-Messungen |
US4360776A (en) * | 1980-09-11 | 1982-11-23 | Bauman Albert J | ESR Based portable microanalytic apparatus and method |
US4475084A (en) * | 1981-01-15 | 1984-10-02 | Picker International Limited | Nuclear magnetic resonance detector |
US4409550A (en) * | 1981-05-15 | 1983-10-11 | President And Fellows Of Harvard College | NMR Sodium images |
DE3123493A1 (de) * | 1981-06-13 | 1982-12-30 | Bruker Analytische Meßtechnik GmbH, 7512 Rheinstetten | Elektromagnet fuer die nmr-tomographie |
US4477777A (en) * | 1981-06-19 | 1984-10-16 | Oxford Research Systems Limited | Analysis of biological material |
DE3129906C3 (de) * | 1981-07-24 | 1996-12-19 | Schering Ag | Paramagnetische Komplexsalze, deren Herstellung und Mittel zur Verwendung bei der NMR-Diagnostik |
DE3139137A1 (de) * | 1981-10-01 | 1983-04-14 | Siemens AG, 1000 Berlin und 8000 München | Geraet zur erzeugung von bildern eines untersuchungsobjektes |
US4456881A (en) * | 1982-01-18 | 1984-06-26 | Technicare Corporation | Gradient-coil apparatus for a magnetic resonance system |
US4511841A (en) * | 1982-06-17 | 1985-04-16 | Chemagnetics, Inc. | Method and apparatus for high speed magic angle spinning |
FI65365C (fi) * | 1982-07-07 | 1984-05-10 | Instrumentarium Oy | Spolanordning |
NL8203621A (nl) * | 1982-09-20 | 1984-04-16 | Philips Nv | Kernspintomograaf met faraday kooi. |
DE3235113A1 (de) * | 1982-09-22 | 1984-03-22 | Siemens AG, 1000 Berlin und 8000 München | Geraet zur erzeugung von bildern eines untersuchungsobjektes mit magnetischer kernresonanz |
CA1198162A (fr) * | 1982-09-23 | 1985-12-17 | Robert D. Hay | Appareil de visualisation a resonnance magnetique nucleaire |
US4510450A (en) * | 1982-09-28 | 1985-04-09 | The Medical College Of Wisconsin, Inc. | Apparatus and assay method for the quantitative determination of mineral content in bone |
US4551678A (en) * | 1982-11-26 | 1985-11-05 | Morgan Tommie J | Phantom for nuclear magnetic resonance machine |
US4516075A (en) * | 1983-01-04 | 1985-05-07 | Wisconsin Alumni Research Foundation | NMR scanner with motion zeugmatography |
NL194579C (nl) * | 1983-01-21 | 2002-08-05 | Schering Ag | Diagnostisch middel. |
US4590427A (en) * | 1983-03-28 | 1986-05-20 | The United States Of America As Represented By The United States Department Of Energy | Nuclear magnetic resonance apparatus having semitoroidal rf coil for use in topical NMR and NMR imaging |
GB2137756B (en) * | 1983-03-30 | 1986-04-30 | Picker Int Ltd | Nuclear magnetic resonance imaging apparatus |
US4531093A (en) * | 1983-05-05 | 1985-07-23 | Southwest Research Institute | Method and apparatus for coal analysis and flow measurement |
US4532473A (en) * | 1983-05-18 | 1985-07-30 | General Electric Company | NMR method for measuring and imaging fluid flow |
US4567440A (en) * | 1983-06-09 | 1986-01-28 | Haselgrove John C | Vivo P-31 NMR imaging of phosphorus metabolites |
FR2548028B1 (fr) * | 1983-06-15 | 1986-09-19 | Hovelian Krikor | Electrode medicale de surface, jetable |
DE3328365A1 (de) * | 1983-08-03 | 1985-02-21 | Schering AG, 1000 Berlin und 4709 Bergkamen | Neue diagnostische mittel |
DE3477788D1 (en) * | 1983-08-05 | 1989-05-24 | Yoshinori Kidani | Cytostatic platinum complexes |
CA1243602A (fr) * | 1983-08-25 | 1988-10-25 | Hong-Ning Yeung | Methode d'accentuation du contraste en imagerie a rmn |
AU3359584A (en) * | 1983-09-29 | 1985-04-04 | Tandem Computers Inc. | Multi level pipeline control store for cpu microsequencing |
GB8329196D0 (en) * | 1983-11-02 | 1983-12-07 | Bydder G M | Nuclear magnetic resonance apparatus |
US4629989A (en) * | 1983-11-10 | 1986-12-16 | General Electric Company | Patient alignment system for NMR studies |
US4615879A (en) * | 1983-11-14 | 1986-10-07 | Vanderbilt University | Particulate NMR contrast agents for gastrointestinal application |
DE3343625C2 (de) * | 1983-11-19 | 1986-10-23 | Bruker Medizintechnik Gmbh, 7512 Rheinstetten | Meßkopf und Verfahren zur Aufnahme hochaufgelöster Kernspinresonanzsignale |
SE463651B (sv) * | 1983-12-21 | 1991-01-07 | Nycomed As | Diagnostikum och kontrastmedel |
US4581582A (en) * | 1983-12-27 | 1986-04-08 | General Electric Company | High-spatial-resolution spectroscopic NMR imaging of chemically-shifted nuclei |
US4583044A (en) * | 1984-01-09 | 1986-04-15 | University Of Utah | NMR imaging method |
DE3400861A1 (de) * | 1984-01-12 | 1985-07-18 | Philips Patentverwaltung Gmbh, 2000 Hamburg | Kernspintomograph |
FI73320C (fi) * | 1984-01-20 | 1987-09-10 | Instrumentarium Oy | Nmr-spolarrangemang. |
US4585992A (en) * | 1984-02-03 | 1986-04-29 | Philips Medical Systems, Inc. | NMR imaging methods |
JPS60190846A (ja) * | 1984-03-10 | 1985-09-28 | Jeol Ltd | 核磁気共鳴装置 |
JPH0634029B2 (ja) * | 1984-04-23 | 1994-05-02 | 三菱電機株式会社 | 高周波コイル |
US4728575A (en) * | 1984-04-27 | 1988-03-01 | Vestar, Inc. | Contrast agents for NMR imaging |
US4609872A (en) * | 1984-08-10 | 1986-09-02 | General Electric Company | NMR multiple-echo phase-contrast blood flow imaging |
US4656026A (en) * | 1984-12-10 | 1987-04-07 | University Of Iowa Research Foundation | Magnetic resonance (MR) image enhancement compounds for specific areas of the brain |
JPS61186843A (ja) * | 1985-02-14 | 1986-08-20 | Jeol Ltd | Nmr−esr同時測定装置 |
GB8522535D0 (en) * | 1985-09-11 | 1985-10-16 | Amersham Int Plc | Contrast agent |
US4834964A (en) * | 1986-03-07 | 1989-05-30 | M.R.I., Inc. | Use of charged nitroxides as NMR image enhancing agents for CSF |
US4719425A (en) * | 1986-04-15 | 1988-01-12 | Scientific Innovations, Inc. | NMR imaging method and apparatus |
US4863717A (en) * | 1986-11-10 | 1989-09-05 | The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of The University Of Oregon | Methods for circumventing the problem of free radial reduction associated with the use of stable nitroxide free radicals as contrast agents for magnetic reasonance imaging |
GB8718515D0 (en) * | 1987-08-05 | 1987-09-09 | Nat Res Dev | Obtaining images |
-
1988
- 1988-06-22 ES ES198888305700T patent/ES2026257T3/es not_active Expired - Lifetime
- 1988-06-22 EP EP88305700A patent/EP0296833B1/fr not_active Expired - Lifetime
- 1988-06-22 EP EP90117826A patent/EP0409292B1/fr not_active Expired - Lifetime
- 1988-06-22 DE DE3851442T patent/DE3851442T2/de not_active Expired - Fee Related
- 1988-06-22 PH PH37102A patent/PH27135A/en unknown
- 1988-06-22 JP JP63505455A patent/JP2690987B2/ja not_active Expired - Fee Related
- 1988-06-22 ES ES90117826T patent/ES2058714T3/es not_active Expired - Lifetime
- 1988-06-22 AU AU19632/88A patent/AU610910B2/en not_active Ceased
- 1988-06-22 WO PCT/GB1988/000479 patent/WO1988010419A1/fr active Application Filing
- 1988-06-22 US US07/295,031 patent/US4984573A/en not_active Expired - Lifetime
- 1988-06-22 IE IE189288A patent/IE61448B1/en not_active IP Right Cessation
- 1988-06-22 DE DE8888305700T patent/DE3865108D1/de not_active Expired - Lifetime
- 1988-06-22 AT AT90117826T patent/ATE111231T1/de not_active IP Right Cessation
- 1988-06-23 NZ NZ225145A patent/NZ225145A/en unknown
-
1989
- 1989-12-11 DK DK622489A patent/DK622489D0/da not_active Application Discontinuation
- 1989-12-18 GB GB8928517A patent/GB2234072B/en not_active Expired - Lifetime
- 1989-12-22 NO NO895229A patent/NO304397B1/no not_active IP Right Cessation
- 1989-12-22 FI FI896234A patent/FI896234A0/fi not_active IP Right Cessation
-
1991
- 1991-09-26 GR GR91401358T patent/GR3002798T3/el unknown
-
1997
- 1997-05-23 JP JP9133118A patent/JP2863744B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
GB2234072A (en) | 1991-01-23 |
NO895229D0 (no) | 1989-12-22 |
EP0296833A1 (fr) | 1988-12-28 |
AU1963288A (en) | 1989-01-19 |
EP0409292B1 (fr) | 1994-09-07 |
NZ225145A (en) | 1991-06-25 |
DE3851442D1 (de) | 1994-10-13 |
WO1988010419A1 (fr) | 1988-12-29 |
AU610910B2 (en) | 1991-05-30 |
FI896234A0 (fi) | 1989-12-22 |
EP0296833B1 (fr) | 1991-09-25 |
GB8928517D0 (en) | 1990-02-21 |
JPH02503995A (ja) | 1990-11-22 |
ES2058714T3 (es) | 1994-11-01 |
DE3851442T2 (de) | 1995-01-19 |
DE3865108D1 (de) | 1991-10-31 |
IE61448B1 (en) | 1994-11-02 |
DK622489A (da) | 1989-12-11 |
DK622489D0 (da) | 1989-12-11 |
JP2690987B2 (ja) | 1997-12-17 |
ATE111231T1 (de) | 1994-09-15 |
EP0409292A2 (fr) | 1991-01-23 |
JP2863744B2 (ja) | 1999-03-03 |
US4984573A (en) | 1991-01-15 |
GB2234072B (en) | 1991-07-03 |
PH27135A (en) | 1993-03-16 |
GR3002798T3 (en) | 1993-01-25 |
JPH1054812A (ja) | 1998-02-24 |
IE881892L (en) | 1988-12-23 |
ES2026257T3 (es) | 1992-04-16 |
EP0409292A3 (en) | 1991-01-30 |
NO895229L (no) | 1989-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO304397B1 (no) | FremgangsmÕte og apparat for Õ generere en avbildning av en pr°ve ved kjernemagnetisk resonans, samt kontrastmedium til bruk i slik fremgangsmÕte | |
EP0351919B1 (fr) | Milieux de contraste contenant des radicaux libres stables | |
US5263482A (en) | Thermographic imaging | |
US5231354A (en) | Magnetic resonance imaging | |
NO334035B1 (no) | Fremgangsmåte for fremstilling av et hyperpolarisert kontrastmiddel for magnetresonansundersøkelse | |
US5203332A (en) | Magnetic resonance imaging | |
AU638985B2 (en) | Magnetic resonance imaging method | |
CA1301248C (fr) | Imagerie a resonance magnetique |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN DECEMBER 2000 |